Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68,514 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor infiltrating mast cells determine oncogenic HIF-2α-conferred immune evasion in clear cell renal cell carcinoma.
Xiong Y, Liu L, Xia Y, Qi Y, Chen Y, Chen L, Zhang P, Kong Y, Qu Y, Wang Z, Lin Z, Chen X, Xiang Z, Wang J, Bai Q, Zhang W, Yang Y, Guo J, Xu J. Xiong Y, et al. Among authors: liu l. Cancer Immunol Immunother. 2019 May;68(5):731-741. doi: 10.1007/s00262-019-02314-y. Epub 2019 Feb 13. Cancer Immunol Immunother. 2019. PMID: 30758643 Free PMC article.
Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses.
Zeng H, Liu Z, Wang Z, Zhou Q, Qi Y, Chen Y, Chen L, Zhang P, Wang J, Chang Y, Bai Q, Xia Y, Wang Y, Liu L, Zhu Y, Dai B, Guo J, Xu L, Zhang W, Xu J. Zeng H, et al. Among authors: liu z, liu l. Int J Cancer. 2020 Jan 15;146(2):542-552. doi: 10.1002/ijc.32715. Epub 2019 Oct 23. Int J Cancer. 2020. PMID: 31584197 Free article.
Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
Qi Y, Chang Y, Wang Z, Chen L, Kong Y, Zhang P, Liu Z, Zhou Q, Chen Y, Wang J, Bai Q, Xia Y, Liu L, Zhu Y, Xu L, Dai B, Guo J, Wang Y, Xu J, Zhang W. Qi Y, et al. Among authors: liu z, liu l. Cancer Immunol Immunother. 2019 Dec;68(12):2067-2080. doi: 10.1007/s00262-019-02429-2. Epub 2019 Nov 12. Cancer Immunol Immunother. 2019. PMID: 31720813 Free PMC article.
Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients.
Xiong Y, Wang Z, Zhou Q, Zeng H, Zhang H, Liu Z, Huang Q, Wang J, Chang Y, Xia Y, Wang Y, Liu L, Zhu Y, Xu L, Dai B, Bai Q, Guo J, Xu J. Xiong Y, et al. Among authors: liu z, liu l. J Immunother Cancer. 2020 Mar;8(1):e000447. doi: 10.1136/jitc-2019-000447. J Immunother Cancer. 2020. PMID: 32217761 Free PMC article.
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients.
Qi Y, Xia Y, Lin Z, Qu Y, Qi Y, Chen Y, Zhou Q, Zeng H, Wang J, Chang Y, Bai Q, Wang Y, Zhu Y, Xu L, Chen L, Kong Y, Zhang W, Dai B, Liu L, Guo J, Xu J. Qi Y, et al. Among authors: liu l. Cancer Immunol Immunother. 2020 Aug;69(8):1565-1576. doi: 10.1007/s00262-020-02563-2. Epub 2020 Apr 18. Cancer Immunol Immunother. 2020. PMID: 32306075 Free PMC article.
Tumor-infiltrating IL-17A+ cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer.
Wang Z, Zhou Q, Zeng H, Zhang H, Liu Z, Huang Q, Xiong Y, Wang J, Chang Y, Bai Q, Xia Y, Wang Y, Zhu Y, Xu L, Dai B, Liu L, Guo J, Xu J. Wang Z, et al. Among authors: liu z, liu l. Oncoimmunology. 2020 Apr 10;9(1):1747332. doi: 10.1080/2162402X.2020.1747332. eCollection 2020. Oncoimmunology. 2020. PMID: 32313725 Free PMC article.
68,514 results
You have reached the last available page of results. Please see the User Guide for more information.